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Choy JS, Lu X, Yang J, Zhang ZD, Kassab GS. Endothelial actin
depolymerization mediates NADPH oxidase-superoxide production during
flow reversal. Am J Physiol Heart Circ Physiol 306: H69–H77, 2014. First
published November 8, 2013; doi:10.1152/ajpheart.00402.2013.—Slow
moving blood flow and changes in flow direction, e.g., negative wall
shear stress, can cause increased superoxide (O2·) production in
vascular endothelial cells. The mechanism by which shear stress
increases O2· production, however, is not well established. We tested
the hypothesis that actin depolymerization, which occurs during flow
reversal, mediates O2· production in vascular endothelial cells via
NADPH oxidase, and more specifically, the subunit p47phox. Using a
swine model, we created complete blood flow reversal in one carotid
artery, while the contralateral vessel maintained forward blood flow as
control. We measured actin depolymerization, NADPH oxidase ac-
tivity, and reactive oxygen species (ROS) production in the presence
of various inhibitors. Flow reversal was found to induce actin depo-
lymerization and a 3.9  1.0-fold increase in ROS production as
compared with forward flow. NADPH oxidase activity was 1.4  0.2
times higher in vessel segments subjected to reversed blood flow
when measured by a direct enzyme assay. The NADPH oxidase
subunits gp91phox (Nox2) and p47phox content in the vessels remained
unchanged after 4 h of flow reversal. In contrast, p47phox phosphor-
ylation was increased in vessels with reversed flow. The response
caused by reversed flow was reduced by in vivo treatment with
jasplakinolide, an actin stabilizer (only a 1.7  0.3-fold increase).
Apocynin (an antioxidant) prevented reversed flow-induced ROS
production when the animals were treated in vivo. Cytochalasin D
mimicked actin depolymerization in vitro and caused a 5.2  3.0-fold
increase in ROS production. These findings suggest that actin fila-
ments play an important role in negative shear stress-induced ROS
production by potentiating NADPH oxidase activity, and more spe-
cifically, the p47phox subunit in vascular endothelium.
endothelial cells
THE MECHANOTRANSDUCTION OF wall shear stress (WSS) has been
a subject of intense investigation (11). Transient near-wall
retrograde flow (negative WSS) occurs during diastole with
each heart beat in peripheral vessels (38). More prominent
retrograde arterial blood flows have been reported in diseased
conditions, especially in heart failure (12). In general, low
blood flow and changes in flow direction cause endothelial
dysfunction, whereas vessel regions that are exposed to steady
blood flow are not as prone to atherosclerosis (14). The
mechanisms that dictate the interplay between WSS and bio-
chemical responses of vessel endothelium are of major interest
in health and atherogenesis. Although the cause of endothelial
cell dysfunction due to change in WSS may be complex,
increased evidence suggests that excessive production of reac-
tive oxygen species (ROS) may play an important role in this
process. We have previously shown that NADPH oxidase has
a directional response to shear stress (15).
The cytoskeleton plays an important role in maintaining
cellular structural integrity through the three-dimensional actin
filament network. It may also mediate the signal transduction
between surface membrane and intracellular target. Actin net-
work disruption has been shown to reduce angiotensin II-
induced Ca2 release in smooth muscle cells (37) or angioten-
sin II-induced ERK1/2 activity (29). It has been confirmed that
fluid shear stress exerts significant influence on the endothelial
cells in cell orientation and morphology, cytoskeleton organi-
zation, signal transduction, growth factor mediation, and gene
expression (7, 11). Endothelial cells can sense differences in
the temporal and/or spatial characteristics of flow and translate
these biochemical stimuli into biological responses (13).
It has been suggested that the endothelial cell membrane
integrin may serve as sensor for WSS (25). Several actin
binding proteins serve as candidates for integrin-mediated
signal transduction (2). In conjunction with external ligands,
integrins activate signaling cascades that regulate the forma-
tion, turnover, and linkage of actin filaments. One of the
outcomes of this pathway may be the change in NADPH
oxidase activity and O2· production. Actin may transmit
surface mechanostimulation to regulate NADPH oxidase.
Currently, there is no in vivo evidence of NADPH oxidase
regulation by actin in the endothelial cells during reversed
flow. Here, we tested the hypothesis that actin depolymeriza-
tion during blood flow reversal induces ROS production in
vascular endothelial cells mediated by NADPH oxidase, pre-
sumably by translocation of p47phox. We provide evidence that
reversed blood flow induces ROS production in endothelial
cells via actin microfilament depolymerization, which potenti-
ates NADPH oxidase activity both in vitro and in vivo.
MATERIAL AND METHODS
Animal preparation. All animal experiments were performed in
accordance with national and local ethical guidelines, including the
Principles of Laboratory Animal Care, the Guide for the Care and Use
of Laboratory Animals (34a), and the National Association for Bio-
medical Research (4), and an approved Indiana University Purdue
University Indianapolis IACUC protocol regarding the use of animals
in research.
Twenty-four Yorkshire pigs (40–55 kg body wt) of either sex were
used in this study. The pigs were fasted overnight, and surgical
anesthesia was induced with TKX (telazol, 10 mg/kg; ketamine, 5
mg/kg; xylazine, 5 mg/kg) and maintained with 1% to 2% isoflurane-
balance O2 during acute, nonaseptic surgery. ECG leads were attached
to the swine limbs. Body temperature was maintained at 37.5 0.5°C
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and pH at 7.4  0.1. At the end of the experiments, the animals were
euthanized under deep anesthesia.
A midincision was made on the neck to expose both carotid arteries
while maintaining an intact adventitia. To create a complete reversed
blood flow in one carotid, two pieces of silicon tubes of the same
length obtained from a blood set (V2410; B. Braun Medical) were
inserted into the proximal (close to the heart) and distal (toward the
head) portions of the vessel and secured with 2-0 silk suture (Fig. 1A).
Two additional silicon tubes were inserted into the contralateral artery
in such way that blood forward flow was maintained (control; Fig.
1B). An ultrasonic perivascular flow probe (Transonic Systems,
Ithaca, NY) was placed around the middle portion of each carotid
artery to monitor flow rate (Fig. 1).
The animals were divided into four groups of six animals each.
Group I was subjected to forward (right carotid) and reversed (left
carotid) flows for 4 h. Group II was subjected to forward and reversed
flows after the endothelium had been denuded in both arteries. Group
III tested the effect of jasplakinolide during reversed flow where the
left carotid was incubated for 10 min with jasplakinolide before the
establishment of flow reversal, while the right carotid was incubated
with saline before forward flow. Group IV tested the effect of
apocynin on both forward (right carotid) and reversed (left carotid)
flows.
The carotid vessels were prepared as shown in Fig. 1A (flow
reversal) and Fig. 1B (forward flow) for 4-h duration. In Group II a
6-mm peripheral dilatation catheter (Guidant, Santa Clara, CA) was
inserted and inflated into the carotid arteries before flow reversal or
forward flow was established. The inflated catheter was pulled and
pushed across the intimal surface 3 times, deflated, and withdrawn to
ensure endothelial denudation. The loss of endothelium-dependent
vasodilation was subsequently confirmed.
In vivo pharmacological treatment. In Group III the left carotid
artery was treated with 0.1 M of jasplakinolide, an actin-stabilizing
agent, and incubated for 10 min before flow reversal was established.
A low concentration of jasplakinolide was used to stabilize the actin
as previously reported (35) to avoid nonspecific effects of higher
concentrations (46). The contralateral vessel was prefilled with saline
before forward flow was established.
In Group IV, a bolus injection of apocynin (4 mg/kg iv) was given to the
animals before the establishment of reversed and forward flows, followed by
continuous infusion (3.5 g·kg1·min1 iv) of apocynin during the entire
experimental procedure. Apocynin is not a specific NADPH oxidase
inhibitor but affects reactive oxygen species (ROS) production by
acting as an antioxidant (19, 44). Apocynin inhibits the release of
O2· by NADPH oxidase by blocking migration of p47phox to the
membrane, critically involved in initiating assembly of the functional
NADPH oxidase complex (40).
After the in vivo experiments, the carotid arteries from all four
groups were quickly removed and placed into a heated (37°C) cham-
ber filled with HEPES buffered PSS containing (in mM) 5.5 D-glu-
cose, 4.7 KCl, 142 NaCl, 2.7 HEPES sodium salt, 1.17 MgSO4, 2.79
CaCl2, at pH 7.4, for ROS/O2· quantification, NADPH oxidase
activity analysis, and protein expression measurements by Western
blotting.
ROS/O2· measurements. The harvested vessels were cut into
3-mm rings and placed into a 96-well plate with HEPES-PSS buffer.
Various compounds [cytochalasin D, latrunculin B, jasplakinolide,
and phorbol 12-myristate 13-acetate (PMA)] were then added to the
corresponding wells. Cytochalasins, a class of fungal metabolites,
inhibit the rate of actin filament polymerization due to inhibition of
actin subunit addition to the fast-growing end of actin filaments, and
are used as actin depolymerization agents (5). Latrunculin B is
commonly used to disrupt the actin cytoskeleton of cells and to block
actin polymerization (32) both in vitro and in vivo. Jasplakinolide is
a potent inducer of actin polymerization and stabilization at low
concentrations (3). PMA is a strong O2· stimulator (activator of
protein kinase C) commonly used as a positive control to stimulate
ROS/O2· production in different types of cells (36). After these
compounds were added, the plate was incubated at 37°C for 30 min.
Finally, L012 (100 M) was added to all wells and the luminescence
was recorded for 60 min at 1-min interval using a multilabel plate
reader (En vision Xcite; Perkin Elmer, Shelton, CT) at ultra-lumines-
cent mode. The total reaction volume was 200 l. After ROS/O2·
quantification, the rings were air dried and weighed. Each condition
was tested in triplicates. ROS levels were measured as relative light
units after subtracting the background luminescence and the number
was divided by the dry tissue weight (mg) of the arterial rings (27).
The values were then normalized to ratio relative to forward flow
condition as the control.
NADPH oxidase activity assay. The arterial samples were placed in
chilled lysis buffer containing 20 mM of KH2PO4, 1 mM of EGTA,
and a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO), and
homogenized with an electric homogenizer (Power Gen 35; Fisher
Scientific) for 20 s. The homogenates were centrifuged at 1,000 g for
10 min at 4°C to remove the unbroken cells and large tissue debris.
The supernatant was collected and kept on ice. The enzyme activity
was determined in 200 l of assay buffer at pH 7.4 containing the
following (in mM): 25 HEPES, 120 NaCl, 5.9 KCl, 1.2 MgSO4, 1.75
Fig. 1. Schematic representation of the ca-
rotid arteries in vivo setup showing the con-
nections made with the silicon tubes at the
proximal (toward the heart) and distal (to-
ward the head) portions of the artery to
create complete blood flow reversal (A) and
blood forward flow (B). The total length of
the arterial segment was 15 cm.
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CaCl2, 11 glucose; 0.1 -NADPH, and 0.1 L012. The reaction started
by adding 10 l of homogenate. The luminescence was measured
every 15 s for 5 min using a plate reader at ultra-sensitive mode. The
protein concentration was determined with a BCA kit (Bio-Rad) and
the results of the enzyme activity were standardized to the protein
level of each sample.
Immunoprecipitation and Western blotting for NADPH oxidase
expression and phosporylation. The arterial vessels were homoge-
nized in the lysis buffer containing 50 mM glycerophosphate, 100 M
sodium orthovanadate, 2 mM magnesium chloride, 1 mM of EGTA,
0.5% Triton X-100, 1 mM DL-dithiothreitol, 20 M pepstatin, 20 M
leupeptin, 0.1 units/ml aprotinin, and 1 mM phenylmethylsulfonyl
fluoride, and then incubated on ice for 1 h. The sample was centri-
fuged at 12,500 rpm for 15 min at 4°C, and the supernatant collected.
The total protein was measured with a BCA kit (Bio-Rad). To
determine the NADPH oxidase expression, equal amounts of protein
(50 g) from each sample were loaded on each lane and electropho-
resed in 4–20% Tris-Glycine gel (Invitrogen) and then transferred
onto a polyvinylidene difluoride membrane (Millipore). After being
blocked for 1 h in 6% dried milk in TBS-Tween buffer, the membrane
was incubated overnight at 4°C with a specific primary antibody
(anti-p47phox and anti-gp91phox; Santa Cruz Biotechnology) at 1:200
dilution in blocking buffer. The membrane was then rinsed and
incubated with a horseradish peroxidase-conjugated secondary anti-
body (Santa Cruz Biotechnology) for 2 h at 1:5,000 dilutions in
blocking buffer. All samples from each group were also probed with
an anti--actin antibody (1:1,000 dilution in blocking buffer; Santa
Cruz Biotechnology) to correct for sample loading.
To quantify p47phox phosphorylation, the total protein with p47phox
was first immunoprecipitated according to an established method (28).
Briefly, the samples were incubated with anti-p47phox at 4°C. They
were then mixed with Protein G PLUS-Agarose (Santa Cruz Biotech-
nology) and incubated for 3 h at 4°C. The samples were then
centrifuged and washed three times with a lysis buffer, and the pallet
was suspended in loading buffer and denatured. The phosphorylated
p47phox was then semiquantified by a rabbit polyclonal antibody to
phosphoserine (Abcam, Cambridge, MA) by Western blotting. For
quantification of phos-p47phox, the levels of total p47phox immuno-
precipitated were first checked by prerun, and the final gel loading was
calculated and confirmed to achieve equal amount of total p47phox
between samples (43).
Actin immunostaining. The carotid vessels were cut into 3-mm
rings and immediately fixed for 2 h in 4% methanol-free formalde-
hyde-PBS solution (Thermo Scientific, Rockford, IL) for actin stain-
ing. Fixed samples were permeabilized with 0.1% Triton X-PBS
solution. After nonspecific sites were blocked with 1% BSA in PBS,
the actin was labeled by incubating the samples with Alexa Fluor
488-phalloidin (Invitrogen, Carlsbad, CA) for 10 min at room tem-
perature. Each sample was then cut into 3  3 mm pieces, mounted
on glass slides, covered with glass cover slips in the presence of 70%
glyceral-PBS, and sealed with glue. The endothelial cytoskeleton was
examined using a confocal microscope (Olympus FV1000-MPE) with
excitation wavelength of 488 nm and emission of 500–530 nm for
detecting actin.
4-Hydroxynonenal immunohistochemistry. Fixed samples were
embedded in paraffin, cut into 3-m thick sections, mounted on glass
slides and processed for immunohistology. Heat-mediated antigen
retrieval was performed using citrate buffer. The samples were
blocked with 5% serum for 30 min at 20°C and then incubated with
a primary antibody against mouse monoclonal 4-Hydroxynonenal
(1:50; Abcam) at 4°C overnight. A goat anti-mouse IgG-FITC (1:100;
Santa Cruz Biotechnology) was used as the secondary antibody.
Sections were counterstained with DAPI while a slide without pri-
mary antibody was used as a negative control. Fluorescence images
were acquired with a ZEISS observer Z1 microscope.
Data analysis. All data were expressed as means SD. Comparisons of
results between two groups were performed by using unpaired two-tailed
t-tests assuming unequal population variance. Multiple group comparisons
were done with ANOVA, and statistical significance among multiple
groups was determined by Tukey tests. P  0.05 was considered
statistically significant.
RESULTS
Endothelial ROS/O2· production in response to blood flow.
We examined the role of actin in flow-induced ROS/O2·
generation where ROS was measured in the carotid arteries
subjected to normal blood forward flow in the absence and
presence of cytochalasin D, latrunculin B, and jasplakinolide.
Basal ROS (control) was detected in the vessels with forward
flow in the absence of treatment (Fig. 2), whereas a fivefold
and twofold increase was found with 10 M cytochalasin D
(p 	 0.004) and 1 M latrunculin B (p 	 0.044) treatments,
respectively (Fig. 2) as compared with the control. ROS levels
remained unchanged with 0.1 M jasplakinolide (Fig. 2).
Similar experiments were also conducted in endothelium
denuded vessels subjected to forward (Fig. 3A) and reversed
blood (Fig. 3B) flows. ROS production was significantly (p 
0.05) reduced in vessels with denuded endothelium subjected
to forward flow (Fig. 3A) and reversed flow (Fig. 3B) with and
without treatment with PMA and cytochalasin D. Treatment
with PMA dramatically reduced ROS generation in endothelial
denuded vessels subjected to both forward (Fig. 3A; p	 0.001)
and reversed blood (Fig. 3B; p 	 0.003) flows, as compared
with vessels with intact endothelium. ROS production was also
reduced in forward (Fig. 3A; p 	 0.04) and reversed (Fig. 3B;
p 	 0.007) flow-endothelium denuded vessels treated with
cytochalasin D. The results suggest that the major source of
ROS/O2· is the endothelial cell.
ROS production was significantly larger (p 	 0.004) in
reversed blood flow vessels, as compared with forward flow
(Fig. 4). Treatment with jasplakinolide, however, significantly
decreased ROS production in reversed flow vessels (p	 0.007;
Fig. 4). Cytochalasin D, which has a general stimulatory effect,
increased ROS production in reversed blood flow, as compared
with forward flow (p 	 0.04; Fig. 4). Pretreatment with
jasplakinolide largely prevented the effects of cytochalasin D
significantly reducing ROS production in reversed flow vessels
(p 	 0.003; Fig. 4).
Fig. 2. Effect of in vitro treatment with cytochalasin D (Cyto-D), latrunculin B
(Latr), and jasplakinolide (Jasp) on reactive oxygen species (ROS) production
of carotid arteries subjected to forward blood flow. Measurements were
determined using chemiluminescence and reported as ratio relative to control
(untreated sample). *P  0.05, experimental groups vs. control.
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Endothelial actin polymerization during flow reversal. To
confirm that flow reversal inhibits actin polymerization in
endothelial cells, the pattern of actin (labeled with fluorescence
conjugated phalloidin) in endothelial cells was examined using
confocal microscopy. Figure 5A corresponds to a carotid seg-
ment with denuded endothelium (negative control). Figure 5B
corresponds to actin endothelial cells during forward flow.
Disruption and clumping was observed in vessels exposed to
reversed flow (Fig. 5C) but to a lesser degree as compared with
vessels treated with cytochalasin D. Cytochalasin D caused
significant disruption of actin filaments during forward blood
flow. Actin filaments appeared disarranged and clumped (Fig.
5D). The changes in actin cytoskeleton were visible when the
concentration of cytochalasin D reached 20 nM. At a concen-
tration 
2 M, all the long actin filament bundles were
disrupted and replaced by large focal aggregates of F-actin.
Treatment with jasplakinolide before and during blood flow
reversal prevented the increase in monomeric actin due to the
disruption of actin cytoskeleton (Fig. 5E), which was found to
be similar to vessels with forward flow.
Flow reversal increased NADPH oxidase activity. Superox-
ide from reversed flow vessels was significantly higher than
the controls, which suggests higher NADPH oxidase activity
during blood flow reversal (Fig. 6A, left). NADPH oxidase
activity was decreased in reversed flow vessels after treat-
ment with jasplakinolide as compared with the control
group, whereas reversed flow-induced ROS production was
abolished in vessels treated with apocynin (Fig. 6A, left).
The results of these experiments were validated by immu-
nostaining of the arterial samples assessed with 4-hy-
droxynonenal-protein adducts, a biomarker of lipid peroxi-
dation (Fig. 6A, right).
NADPH oxidase protein levels were determined by West-
ern blot. The levels of two major subunits, gp91phox (Nox2)
and p47phox, are shown in Fig. 6B. The ratio of protein band
density between reversed flow and forward flow vessels was
close to unity, which suggests equal levels of protein ex-
pression under these conditions. The expressions of these
subunits did not change after treatment with jasplakinolide.
The protein expression of gp91phox and p47phox in forward
and reversed flow samples, untreated and treated with jas-
plakinolide, are shown in Fig. 6C. Western blot bands of
gp91phox and p47phox from carotid vessels and white blood
cells (WBC) with their corresponding molecular weights are
shown in Fig. 6D.
Blood flow reversal and actin depolymerization increased
p47phox phosphorylation. We examined p47phox phosphoryla-
tion to understand the molecular basis for increased ROS/
O2· production subsequent to actin depolymerization and
blood flow reversal. As shown in Fig. 7A, treatment with
PMA and cytochalasin D induced increased p47phox phos-
phorylation as compared with control (p  0.05 in both
cases). Under in vivo conditions, p47phox phosphorylation
was also increased in vessels exposed to reversed blood flow
as compared with those with forward flow (Fig. 7B; p Fig. 3. Effect of endothelial denudation on ROS production of carotid arteriessubjected to forward blood flow (A) and reversed blood flow (B). The vessels
were stimulated in vitro with phorbol 12-myristate 13-acetate (PMA) and
Cyto-D. *P  0.05, denuded vs. intact endothelium.
Fig. 4. Effect of reversed blood flow on ROS production in carotid vessels
treated in vivo with Jasp and then stimulated in vitro with cytochalasin D.
*P  0.05, reversed vs. forward; **P  0.05, reversed  Jasp vs. reversed;
*^P 0.05, reversed vs. forward in CytoD group; **^P 0.05, reversed Jasp
vs. reversed in CytoD group.
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0.05). Figure 7C shows the p47phox protein expression
before and after immunoprecipitation in carotid vessels
subjected to forward and reversed flow.
DISCUSSION
The major finding of this study was that the directionality of
the mechanical loading (positive vs. negative WSS) on actin
filaments plays an important role in the activity of the NADPH
oxidase system in vascular endothelial cells. The findings
suggest that actin depolymerization, which occurs during re-
versed blood flow, activates the NADPH oxidase system via
p47phox phosphorylation, which induces ROS (mainly O2·
production). These novel observations may reveal the mecha-
nisms of this mechanical-biochemical interaction, which has
pathological implications for atherogenesis.
The regulation of NADPH oxidase has been mostly studied in
phagocytes where disruption of actin polymerization potentiates
O2· production (22). Activation of phagocytic NADPH oxidase
requires serine phosphorylation of the cytosolic p47phox, p67phox,
and p40phox components, assembly of the phosphorylated subunits
with Rac2, and translocation to the phagosomes for association
with cytochrome b558 reductase, which consists of p22phox and
gp91phox (Nox2) (45). The endothelial NADPH oxidase (Nox)
shares many similarities with that of phagocytes. All the
classical NADPH oxidase subunits are expressed in endothelial
cells (17), and recent studies have indicated that several novel
Fig. 5. Immunostaining of carotid artery endothelial cells under different conditions. Denuded endothelium (negative control), forward blood flow, reversed blood
flow, forward blood flow  cytochalasin D treatment, and reversed blood flow  jasplakinolide treatment, respectively, are shown. Scale bar 	 10 m.
Fig. 6. A: effect of reversed blood flow on NADPH oxidase activity. Data are expressed as the ratio between reversed flow and forward flow (RF/FF), reversed
flow  Jasp and forward flow (RF  Jasp/FF), and reversed flow and forward flow  apocynin (RF/FF  Apo) (left). Carotid arterial sections were
immunostained with anti-4-hydroxynonenal (HNE) protein (green). Scale bar 	 20 m (right). B: effect of reversed blood flow vs. forward blood flow on
NADPH oxidase protein expression (gp91phox and p47phox) determined by Western blot in samples untreated and treated with jasplakinolide. C: protein
expression of gp91phox and p47phox in forward and reversed flow samples, untreated (left) and treated (right) with jasplakinolide. D: Western blot bands of
gp91phox and p47phox from carotid vessels and white blood cells (WBC). DAPI, 4, 6-diamidino-2-phenylindole. *P  0.05, RF/FF vs. FF/FF; **P  0.05,
RF  Jasp/FF vs. RF/FF; **^P  0.05, RF/FF  Apo vs. RF/FF.
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Nox family isoforms, in addition to Nox2 (formerly known as
gp91phox), are highly expressed in vascular endothelial and
smooth muscle cells (45). The mRNA and protein of p22phox
can be detected in both endothelial and smooth muscle cells. In
contrast, the expression of gp91phox (Nox2) is confined to
endothelial cells (17). In nonstimulated endothelial cells, a
proportion of the NADPH oxidase enzyme exists as a preas-
sembled intracellular complex associated with the cytoskeleton
in mainly perinuclear distribution (23). Endothelial oxidase
constitutively generates small amounts of O2· in nonstimu-
lated cells, which is in agreement with our findings of basal
constitutive production of ROS in the intact vessel (Figs. 2–4).
The interaction of actin and NADPH oxidase in endothelial
cells is not well understood (1). Although the regulation of
NADPH oxidase has been widely investigated in phagocytes,
the data cannot be directly translated to endothelial cells.
Protein kinase C has been shown to play a role in NADPH
oxidase regulation in both phagocytes and nonphagocytes (8,
20). Cytochalasin D-induced O2· production, however, is
protein kinase C independent in phagocytes (22). Our findings
in endothelial cells suggest that cytochalasin D does induce
ROS/O2· production (Figs. 2–4).
NADPH oxidase regulation may vary depending on cell
type. Many previous studies have focused on NADPH oxidase
and actin interaction in nonphagocytes under culture condi-
tions. In these studies, increased depolymerization enhanced
ROS production (26, 30, 35, 45), which is in agreement with
our findings. The actin network in cultured cells, however,
differs from primary cells, where cells in different stages of
culture conditions migrate and maintain different surface ten-
sions, which require variable actin polymerization and depo-
lymerization rates. Therefore, the findings from culture cells
should be tested under in vivo conditions.
A novel finding of this study is that actin depolymerization-
mediated reversed blood flow induces ROS production in
endothelial cells in vivo by increasing p47phox phosphoryla-
tion. Nam et al. (34) have also demonstrated ROS production
in a p47phox-dependent manner in a mouse model of partial
carotid ligation and disturbed flow. DHE staining intensity in
the vessel walls of carotid arteries subjected to disturbed flow
was significantly higher than that of vessels with normal flow,
which suggests that ROS was produced in response to dis-
turbed flow in a p47phox NADPH oxidase-dependent manner
(34). Similarly, Castier et al. (6) also found that ROS produc-
tion is enhanced in mice carotid arteries exposed to chronic
high flow. They also showed that the p47phox subunit was the
major generator of shear stress-induced ROS in the vascular
wall. In this study, under blood flow reversal, ROS production
was increased (Fig. 4) and actin depolymerization was ob-
served in endothelial cells (Fig. 5C). The increase in ROS
production was prevented by stabilizing the actin filaments
with an actin stabilizer, jasplakinolide (Figs. 2 and 5E). Jas-
plakinolide is a cyclo-depsipeptide commonly used as an actin
filament polymerizing and stabilizing drug (3). It is membrane
permeable and can easily diffuse into the cells and selectively
binds to F-actin. A low concentration (nanomolar range) of
jasplakinolide was used in this study, which has been shown to
be an effective dose (35). Jasplakinolide did not change basal
ROS production (Fig. 2), suggesting that the change that
occurred after treatment with jasplakinolide was not due to cell
damage. To support this finding, we also showed that ROS
production was increased in intact vessels under in vitro
conditions when actin filaments were depolymerized by cy-
tochalasin D (Fig. 2). In phagocytes, cytochalasins have been
shown to induce or potentiate ROS/O2· production via
NADPH oxidase (33). To confirm that this was not due to
nonspecific effects, we showed that latrunculin B, another
actin polymerization inhibitor, activated ROS/O2· produc-
tion (Fig. 2).
Several cytoplasmic components of the NADPH oxidase are
associated with the actin cytoskeleton (40, 47). This associa-
tion is not permanent but inducible, as suggested by the fact
that VEGF stimulation of endothelial cells triggers transloca-
tion of p47phox to the membrane ruffles, where the most active
actin reorganization takes place (47). We speculate that actin
depolymerization due to flow reversal regulated p47phox serine
phosphorylation and facilitated p47phox translocation, i.e., in-
Fig. 7. A: in vitro p47phox phosphorylation in untreated and treated samples with PMA and cytochalasin D with their corresponding protein expression. *P 
0.05, PMA or CytoD vs. control. B: in vivo p47phox phosphorylation during forward flow and reversed flow experiments with their corresponding protein
expression. The loading controls were from different blots. *P  0.05, reversed vs. forward. C: p47phox protein expression before (pre) and after (post)
immunoprecipitation (IP) of carotid vessels subjected to forward and reversed flow. Post-IP samples were double loaded.
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creased NADPH oxidase activity, as seen in Figs. 6, B and C,
and 7, C and D.
The NADPH oxidase enzyme assay supports the hypothesis
that flow reversal increases the formation of the NADPH
oxidase complex (Fig. 6A), and jasplakinolide prevented this
elevation. The NADPH oxidase enzyme assay was performed
in tissue homogenate after removal of intact cells and mito-
chondria by centrifugation. The ROS produced by this assay
was derived from preformed and activated enzyme complex.
As shown by Western blot, the protein levels were unchanged
(Fig. 6B), which suggests that the increased in enzyme activity
was not due to increased oxidase expression. Apocynin
blocked the translocation of NADPH oxidase subunits. The
enzyme activity was reduced in vessels from animals treated
with apocynin (Fig. 6A). Various forms of actin polymer may
have different binding affinity and effects on NADPH oxidase.
For example, in a cell-free system, the addition of G-actin
activated human neutrophil NADPH oxidase (31), whereas the
addition of F-actin did not enhance oxidase activation. An actin
binding site was identified in p47phox (41). The present study
showed that increased depolymerization of actin facilitated
ROS production (Figs. 2 and 4). This may be partially due to
increased G-actin around NADPH oxidase, which presumably
facilitated p47phox phosphorylation and translocation (i.e., up-
regulated enzyme activity). Although this study only focused
on two subunits of the NADPH oxidase complex (Nox2 and
p47phox), future studies should consider the role of other
subunits in flow reversal, like Nox4, which has been shown to
be regulated by shear stress (16, 21).
Study limitations. First, the origin of ROS (mainly O2·) was
not directly determined. There are several enzymatic sources of
ROS in mammalian cells, including NADPH oxidase system,
mitochondrial electron transport chain, xanthine oxidase, and
cytochrome p450 (23). Among these, the major source of
ROS/O2· in endothelial cells is the NADPH oxidase system
(1). In our vessel preparation, ROS/O2· was primarily derived
from the endothelial cells. Removal of the endothelial layer
decreased ROS/O2· production by nearly 80% in all vessels
(under various conditions). In support of our findings, others
have shown that PMA stimulates ROS production in aortic
segments only when the endothelial layer is intact (17). In the
same study, PMA stimulated ROS production in cultured
endothelial cells, but not in cultured smooth muscle cells. We
have previously shown (15) in an in vitro blood vessel prepa-
ration that the major source of ROS/O2· during complete
reversed flow is the NADPH oxidase.
Second, an accurate method for real time direct measure-
ment of ROS in vivo does not exist. We used a chemilumines-
cence probe, L-012, for ROS detection. Previous studies (9, 39)
have shown that L-012 is a very sensitive probe for ROS
measurement in cell free assay, isolated cells, or whole tissue.
This probe has also been validated for ROS measurements in
vascular tissues (9, 39). L-012 has also been shown to detect
peroxynitrite in cell free solutions in the presence of nitric
oxide (NO) (10) and hence raises the concern that NO might
interfere with ROS measurement. L-012 also detects peroxyni-
trite in isolated mitochondria, but requires much higher con-
centration of NO. L-012, when used in intact tissue, predom-
inantly detects extracellular O2·. The contribution of per-
oxynitrite in L-012 signal in our study is likely to be less than
that from ROS. In future studies, other methods to confirm
ROS measurements as well as specific scavengers may be used
concomitantly with L-012.
Third, jasplakinolide paradoxically stabilizes actin filaments
in vitro, but it can disrupt actin filaments and induce polym-
erization of monomeric actin into amorphous masses in vivo.
Our results show that the activation of NADPH oxidase is
regulated by actin polymerization/depolymerization and that
jasplakinolide attenuates ROS production from NADPH oxi-
dase. The mechanistic regulation of actin polymerization/depoly-
merization on NADPH oxidase is unclear. We speculate that the
concentration of monomeric actin may regulate the activation of
NADPH oxidase through the translocation of cytoplasmic sub-
units of NADPH oxidase, e.g., p47phox. Therefore, administration
of jasplakinolide decreases the concentration of monomeric actin
by the polymerization of monomeric actin into an amorphous
mass, even if jasplakinolide does not stabilize actin filaments in
endothelial cells. Clearly, the mechanism of actin-NADPH oxi-
dase interaction needs to be further studied.
Finally, there is a possible contribution of infiltrating leuko-
cytes to the ROS/O2· production in the carotid artery prepa-
rations; however, vessels were harvested fresh from the ani-
mals, and hence, unlikely to have significant infiltration of
leukocytes. Furthermore, vessels subjected to reversed and
forward flows were obtained under identical conditions. In
addition, when the vessel was denuded, the O2· production
was dramatically reduced, which suggests that the endothelium
was a predominant source of ROS/O2·. We quantified IL-8 in
the carotid vessels using ELISA. The presence of leukocytes in
these specimens was not significantly different in reversed flow
versus forward flow with intact (p 	 0.98) and denuded (p 	
0.92) endothelium, reversed flow with and without jasplakino-
lide treatment (p 	 0.60), and reversed flow versus forward
flow in the presence of apocynin (p 	 0.98). Hence, the
contribution of leukocytes to the relative ROS/O2· production
was either small or similar in control and treated vessels.
Conclusions
This study demonstrated that actin cytoskeleton plays an
important regulatory role in reversed blood flow-induced
ROS/O2· production from NADPH oxidase in vascular
endothelial cells. Negative shear stress leads to actin net-
work reorganization, which induced p47phox phosphoryla-
tion and NADPH oxidase complex formation and ROS/O2·
production. Our results suggest that actin stabilization may
be protective in vascular regions of blood flow reversal
prone to atherogenesis.
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